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Abstract
NUP98 is a recurrent fusion partner in chromosome translocations that cause acute myelogenous leukemia.
NUP98, a nucleoporin, and its interaction partner Rae1, have been implicated in the control of chromosome
segregation, but their mechanistic contributions to tumorigenesis have been unclear. Here, we show that
expression of NUP98 fusion oncoproteins causes mitotic spindle defects and chromosome missegregation,
correlating with the capability of NUP98 fusions to cause premature securin degradation and slippage from
an unsatisﬁed spindle assembly checkpoint (SAC). NUP98 fusions, unlike wild-type NUP98, were found to
physically interact with the anaphase promoting complex/cyclosome (APC/C)Cdc20 and to displace the BubR1
SAC component, suggesting a possible mechanistic basis for their interference with SAC function. In addition,
NUP98 oncoproteins displayed a prolonged half-life in cells. We found that NUP98 stability is controlled by a
PEST sequence, absent in NUP98 oncoproteins, whose deletion reproduced the aberrant SAC-interfering
activity of NUP98 oncoproteins. Together, our ﬁndings suggest that NUP98 oncoproteins predispose myeloid
cells to oncogenic transformation or malignant progression by promoting whole chromosome instability. Cancer
Res; 74(4); 1079–90. !2013 AACR.
Introduction
NUP98 represents one of the most "promiscuous" (1)
partner genes in chromosomal translocations causing acute
myelogenous leukemias (AML), as it is involved in the
formation of fusion oncoproteins with more than 20 differ-
ent proteins, among which nine HOX family members (1, 2).
Homeodomain-containing transcription factors belonging
to the HOX family play crucial roles in embryonic develop-
ment (reviewed in refs. 3, 4). HOX genes can participate in
oncogenesis through their involvement in chromosomal
translocations. These lead in some cases to the formation
of fusion oncoproteins, composed of the N-terminal part of
the NUP98 protein, and usually the homeodomain portion
of a HOX protein (1, 2, 5). NUP98 codes for a nucleoporin,
which is involved in the transport of proteins and RNA
across the nuclear membrane (6–9). The NUP98 protein
contains two partially characterized functional domains: a
GLFG repeat region, which serves as a nuclear transport
receptor docking surface (8, 10), and a Gle2 binding se-
quence (GLEBS) domain, which mediates the interaction
with the RAE1 mRNA nuclear export factor (11). Both
domains are located within the N-terminal half of NUP98,
which is present in essentially all fusion oncoproteins (1, 5).
For many chromosomal translocations causing cancer, the
functional characterization of the components of the onco-
genic fusion proteins proved to be crucial to understand the
transformation process. NUP98-HOX chimeric proteins, for
instance, as they contain a functional DNA-binding domain
(DBD), the homeodomain, are held to exert their oncogenic
potential via the misregulation of HOX target genes
(2, 5, 12, 13). Other reports, however, have challenged this
view, showing that theHOXhomeodomainmay be dispensable
(14, 15). These results would suggest that the NUP98 moiety
may play an additional role(s) in the oncogenic process, not
directly related to transcriptional regulation. A mechanism(s)
not exclusively involving transcriptional misregulation would
moreover account for oncogenic NUP98 fusion proteins
that do not involve transcription factors, yet cause related
malignancies (1).
Chromosomal instability due to deregulation of mitotic
checkpoint inhibition of the anaphase promoting complex/
cyclosome (APC/C) function has been shown to increase the
susceptibility to malignant transformation (16–18). Indeed,
misregulation of APC/C components has been reported to be
associated with human malignancies (19–22). The APC/C
regulates mitosis and cell-cycle progression by targeting a
series of key substrates for degradation during mitosis. One
of these is securin (23), an anaphase inhibitor protein that
blocks the action of the cohesin-degrading protease separase
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(24). APC/C activity is controlled during mitosis by the
spindle assembly checkpoint (SAC), which senses the correct
attachment of kinetochores to spindles and blocks APC/C
function, preventing sister chromatid separation until all
kinetochores are properly attached (reviewed in ref. 25).
Despite the established role of the Cdc20-controlled
APC/CCdc20 in securin degradation (26), Nup98 and its hetero-
dimerization partner Rae1 (11) have been proposed to be
implicated in APC/CCdh1-mediated securin ubiquitination
during early mitosis (27). Interestingly, NUP98 shares with the
SAC factors and APC/C regulators Bub1 and BubR1 a GLEBS
domain, which serves in these proteins as an interaction
surface with Bub3, also a regulator of mitosis sharing homo-
logy with Rae1 (28, 29).
In this work, we explored whether the expression of
NUP98 fusion oncoproteins would affect the process of
chromosome segregation. We found that the exogenous
expression of three different NUP98 fusions causes mitotic
spindle defects and chromosome missegregation, which cor-
relate with an aberrant, untimely degradation of securin, and
slippage from an unsatisﬁed SAC. NUP98 oncoproteins,
unlike wild-type NUP98, were found to physically interact
with the APC/CCdc20, thus providing a mechanistic basis for
the observed interference with SAC function. We show in
addition that NUP98 oncoproteins have an anomalously
prolonged intracellular half-life and that the stability of
NUP98 depends on a PEST sequence located within the
C-terminal portion that is absent in NUP98 oncoproteins.
A PEST sequence deletion mutant reproduces the interfer-
ence with APC/C function displayed by NUP98 oncoproteins.
Our results, by establishing the involvement in APC/C mis-
regulation of the common NUP98 N-terminal portion, point
to a possible oncogenic mechanism, likely shared by all
NUP98 fusions, based on chromosome instability.
Materials and Methods
Plasmid constructs
For details on plasmid construction see Supplementary
Materials and Methods.
Cell culture, transfection, and retroviral transduction
HEK293 (American Type Culture Collection; #CRL-1573)
human embryonic kidney cells and human primary ﬁbroblasts
(hPF) were cultured in Dulbecco's Modiﬁed Eagle Medium
(Celbio ECB7501L-50). The retroviral vector expressing
NUP98-HOXD13 (LND13IDN) and the empty vector (LXIDN)
were used to obtain viral stocks by transient transfection of
ampho-phoenix human packaging cell line as described pre-
viously (30). For further details on transfection and retroviral
transduction, see Supplementary Materials and Methods.
Cell synchronization
HEK293 cells and hPFswere synchronized in G2–Mphase by
treatmentwith 0.2mg/mLnocodazole (Sigma) and collected at
indicated times. For further details on mitotic spreads prep-
aration of HEK293 and primary ﬁbroblasts see Supplementary
Materials and Methods.
Protein knockdown with siRNAs
siRNA duplexes targeting the coding sequence of human
CDH1 and CDC20, as well as siRNA control duplexes were
synthesized by Invitrogen [Stealth siRNA duplexes, 25mer
and Stealth RNAi–Negative Control Duplexes (12935-400)].
Two different siRNA duplexes were designed targeting the
CDC20 (CDC20HSS101650 and CDC20HSS101651), or the
CDH1 (FZR1HSS122071 and FZR1HSS122072) mRNAs. siRNA
transient transfection in HEK293 cells was performed using
40 pmol/L of RNAi duplexes per 6 cm wells, using lipofecta-
mine 2000 (Invitrogen; 11668-027) following the manufac-
turer's protocol. Protein depletion was detected by Western
blot analysis 48 hours after siRNA transfection.
Antibodies, coimmunoprecipitation, and
immunoblotting
For details on antibodies, coimmunoprecipitation, and
immunoblotting see Supplementary Materials and Methods.
Immunoﬂuorescence staining and mitotic spreads
Methods for immunoﬂuorescence stainings and mitotic
spreads are described in Supplementary Materials and
Methods.
Mitotic checkpoint release in vitro
Nocodazole-arrested cell extracts preparation fromHEK293
cells were obtained as described in (31) with the variation that
cells were sonicated 1000 after lysis. For further details see
Supplementary Materials and Methods.
Results
Expression of NUP98-HOXD13 and of two other NUP98
fusion oncoproteins causes mitotic spindle defects and
chromosome missegregation
To verify the effect of NUP98 fusion oncoproteins on
chromosome segregation, we exogenously expressed the
NUP98-HOXD13, NUP98-LOC348801, and NUP98-HHEX
fusions in hPF and HEK293 human embryonic kidney cells.
These fusion proteins all originate from AML-associated
chromosomal translocations involving the NUP98 gene,
located on chromosome 11. They all contain a large portion
of the N-terminal part of the NUP98 protein spanning the
GLFG and GLEBS motifs (Supplementary Fig. S1A). NUP98-
HOXD13 is generated by t(2;11)(q31;p15) translocations, and
represents a fusion with the C-terminal homeodomain DNA-
binding moiety of the HOXD13 protein (32). The NUP98-
LOC348801 fusion (hereafter indicated as NUP98-LOC) is
the product of a t(3;11)(q12;p15) translocation, which gives
rise to a fusion protein, containing the C-terminal portion
of a polypeptide of unknown function, encoded by the
LOC348801 gene (33). Finally, NUP98-HHEX originates from
a t(10;11)(q23;p15) translocation producing a fusion protein
that incorporates the homeodomain of the hematopoieti-
cally expressed homeobox gene (HHEX; ref. 34).
We initially tested the effect of NUP98 oncoprotein expres-
sion in HEK293 cells, which are transiently transfected
with high efﬁciency. Substantial percentages (80%–85%) of
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transfected HEK293 cells were achieved with the expression
constructs for the three oncoproteins (not shown). The
potential occurrence of abnormal mitoses was investigat-
ed by immunoﬂuorescence staining using anti-a-tubulin
antibodies. NUP98-HOXD13, NUP98-LOC, or NUP98-HHEX
expression caused a considerable increase in the proportion
of cells displaying abnormal mitoses, including multispindles
and anaphases with lagging chromosomes being deﬁned as
chromosomes tardily drawn to their spindle poles, which will
eventually fail to be included in the reforming nuclei (Fig. 1A;
and not shown), up to 24%, 30%, and 20% of total, respec-
tively (Table 1A). Thus, this indicates that the expression of
these fusion proteins interferes with the normal process of
chromosome segregation. Conversely, expression of wild-
type HOXD13 or wild-type NUP98 did not, or only modestly
altered the frequency of abnormal mitoses observed in mock-
transfected cells, respectively (Table 1A). The results
obtained with the NUP98-HOXD13 chimera were also con-
ﬁrmed in primary cells. hPF were transduced with a retro-
viral construct expressing NUP98-HOXD13 (ND13; Table 1B),
or with the control empty retroviral vector. Also in hPFs,
NUP98-HOXD13 expression caused a substantial increase in
the percentage of abnormal mitoses (Table 1B and Fig. 1A,
bottom).
We next wanted to verify whether the observed increase in
abnormal mitoses would result in variations in chromosome
numbers. Metaphase spreads of HEK293 cells were prepared
after 48 hours from transfection. Cells expressing NUP98-
HOXD13, NUP98-LOC, or NUP98-HHEX showed substantially
increased frequencies of aneuploid ﬁgures, 78%, 74%, and
70%, respectively (Table 1A; Fig. 1B, and not shown). In the
same conditions, the expression of wild-type HOXD13 did not
signiﬁcantly alter the frequency of aneuploid cells observed
in control mock-transfected cells (Table 1A). Similarly, the
expression of wild-type NUP98 did only modestly affect
the frequency of aneuploid metaphases (Table 1A). Also in
hPF cells, NUP98-HOXD13 expression caused a substantial
increase in the frequency (up to 85% of expressing cells)
of metaphases showing abnormal chromosome numbers
(Fig. 1B and Table 1B).
As both NUP98-LOC and NUP98-HHEX were expressed as
GFP fusion proteins (GFP-NLOC and GFP-NHEX in Table 1),
Figure 1. NUP98-HOXD13
expression causes aberrantmitotic
ﬁgures and aneuploidy in HEK293
and hPF. A, immunoﬂuorescence
staining of HEK293 or hPF. Mitotic
ﬁgures observed in control cells
(HEK), transfected with the empty
vector, or in NUP98-HOXD13-
expressing cells (HEK ND13),
during metaphase, anaphase,
and telophase. Arrowheads,
multispindles; arrow, a lagging
chromosome (see text). The slides
were ﬁxed and stained with an
anti-a-tubulin primary antibody
and a tetramethyl rhodamine
isothiocyanate-conjugated
secondary antibody (red). Nuclei
were counterstained with
40,6-diamidino-2-phenylindole
(DAPI, blue). B, mitotic spreads.
Examples are shown of the
chromosomal abnormalities
observed in cells expressing
NUP98-HOXD13 (ND13) or in
control cells transfected with the
empty vector (HEK CTRL).
Arrowheads in panels and in
enlarged areas indicate aberrantly
disjoined sister chromatids. For
chromosome counting, the slides
were stained with DAPI. Of note,
300 mitotic spreads for each cell
line were analyzed.
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we also generated a GFP-NUP98-HOXD13 fusion (GFP-ND13)
as a control. GFP-ND13 expression produced essentially the
same frequency of aneuploid cells (75%) as NUP98-HOXD13
expression (Table 1), thus excluding a role for the GFP moiety
in the observed mitosis and karyotype alterations.
To assess whether the aneuploidies caused by NUP98 fusion
oncoproteins are compatible with cell viability, HEK293 cells
were transduced with the NUP98-HOXD13 (pCCL-ND13) or
with the empty control (pCCL) lentiviral expression vectors,
and stably expressing clones were isolated and analyzed for
variations in chromosome number. Of note, 50% of the isolated
clones expressing NUP98-HOXD13 showed varying degrees
of aneuploidy, whereas only 5% of the clones carrying the
empty control vector displayed aberrant chromosome num-
bers (Table 1C). These data show that stable enforced expres-
sion of NUP98-HOXD13 signiﬁcantly raises the frequency of
aneuploid cell clones and that the induced aneuploidies can
be compatible with cell viability.
We next wanted to verify whether DNA binding was
essential to the capability of NUP98-HOXD13 to cause aber-
rant mitoses and aneuploidy. We thus generated a NUP98-
HOXD13 mutant derivative, NUP98-HOXD13IQN, carrying
Table 1. NUP98 chimeric fusion proteins induce aberrant mitoses and aneuploidy in HEK293 and hPF
A
Cells with indicated
chromosome number
HEK
% of
aneuploid
ﬁgures SD <67 67 >67
% of
abnormal
mitosis SD
Control 6 2 4 94 2 3 1
D13 4 2 2 96 2 3 1
N98 16 3 10 84 6 9 1
ND13 78 6 58 22 20 23 2
ND13IQN 76 7 49 24 27 34 7
GFP-ND13 75 10 55 25 20 24 2
GFP-NLOC 74 8 50 26 24 30 6
GFP-NHHEX 70 11 29 30 41 20 2
B
Cells with indicated
chromosome number
hPF
% of
aneuploid
ﬁgures SD <46 46 >46
% of
abnormal
mitosis SD
Control 5 1 3 96 2 2 0
ND13 85 7 67 32 18 35 3
C
Clones with indicated
chromosome number
HEK Clones
% of
aneuploid
clones <67 67 >67
Number of
aneuploid
clones
Fixed
aneuploid
pattern
pCCL 5 1 19 0 1/20 0/1
pCCL-ND13 50 8 10 2 10/20 7/10
NOTE: Mitotic spindle alterations and aneuploidies observed: A, in HEK293 cells expressing FlagHOXD13 (D13), NUP98 (N98),
NUP98HOXD13 (ND13), NUP98HOXD13IQN (ND13IQN), EGFP-NUP98HOXD13 (GFP-ND13), EGFPNUP98LOC348801 (GFP-
NLOC), EGFPNUP98HHEX (GFP-NHHEX), or transfected with the control empty expression vector (Control); B, in hPF transduced
with the LND13IDN (ND13) retroviral vector expressing NUP98HOXD13, or with the LXIDN control empty vector (control). Of
note, 300 mitotic ﬁgures and mitotic spreads were analyzed for each construct. SD of three independent experiments is shown.
The modal chromosome number is 67 for HEK293. hPFs displayed a normal (46, XY) karyotype; C, single clones of stably transfected
HEK293 cells were isolated and analyzed by mitotic spreading for aneuploidy. Seven of the 20 NUP98-HOXD13 clones showed
a ﬁxed, uniform aneuploid pattern (i.e., more than 95%of the cells within the clone displayed the same aberrant chromosome number),
whereas 3 clones showed various degrees of aneuploidy, none of which were represented in more than 50% of the cells.
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mutations within the homeodomain that abolish DNA bind-
ing (35). NUP98-HOXD13IQN expression resulted in percen-
tages of abnormal mitoses and aneuploid metaphases super-
imposable to those caused by NUP98-HOXD13 (Table 1A).
Taken together, these results showed that the exogenous
expression of three different NUP98 fusion oncoproteins
causes substantial perturbation of the chromosome segre-
gation process both in primary as well as in immortalized
cells in a DNA-binding–independent manner. These data
furthermore suggested a possible interference by NUP98
fusions with the APC/C-controlled activation of chromo-
some separation.
NUP98-HOXD13, NUP98-LOC, and NUP98-HHEX
expression causes untimely securin degradation
We next investigated whether the expression of NUP98-
containing fusion oncoproteins would perturb SAC function
and APC/C activity. NUP98-HOXD13, NUP98-LOC, or
NUP98-HHEX were expressed in HEK293 cells (Supplemen-
tary Fig. S1B). Twenty-four hours after transfection, cells
were arrested in M phase by treatment with the microtu-
bule-depolymerizing, SAC-activating drug nocodazole. They
were subsequently harvested at different time points, to
analyze securin protein levels in total cell extracts, as an
indication of the capability of the cells to overcome cell-cycle
arrest. Immunoblot analysis of total cell extracts showed no
changes in securin amounts in HEK293 cells expressing
HOXD13, NUP98, or in mock-transfected cells, even 32 hours
after nocodazole treatment (Fig. 2A). In cells expressing
NUP98-HOXD13, NUP98-LOC, NUP98-HHEX, or NUP98-
HOXD13IQN, however, a marked decrease in securin
amounts was observed, starting 24 hours after nocodazole
treatment, (Fig. 2A). In these same cells, lower-level varia-
tions in cyclin B1 and geminin amounts were detected only
32 hours after nocodazole treatment (Fig. 2A). To conﬁrm
that the observed reductions in securin levels are due to
securin degradation, cells were treated in addition with the
proteasome inhibitor MG132. In the presence of MG132,
no variations in securin amounts were observed in noco-
dazole-arrested, NUP98-HOXD13, NUP98-LOC, or NUP98-
HHEX expressing cells, demonstrating the proteasome-
mediated degradation of securin (Supplementary Fig. S2).
Coherently with the reduction in securin levels, nocodazole-
arrested cells expressing NUP98-HOXD13, NUP98-LOC,
NUP98-HHEX, or NUP98-HOXD13IQN showed a sensible
reduction of their mitotic indexes, indicating premature slip-
page from the unsatisﬁed SAC (Fig. 2B). The mitotic index of
nocodazole-treated control, mock-transfected and NUP98-
expressing HEK293 cells, instead, did not change signiﬁcantly
within the analyzed time frame, allowing us to exclude spon-
taneous mitotic slippage in these cells in our experimental
conditions (Fig. 2B). No spontaneous escape from the noco-
dazole arrest could be observed in HEK293 cells even at later
time points, whereas U937 cells, which were treated in parallel,
showed a considerable fraction of cells spontaneously slipping
into mitosis (Supplementary Fig. S3A). If not treated with
Figure 2. NUP98 fusion oncoproteins cause untimely securin degradation. A, immunoblot analysis showing APC/C substrate levels in nocodazole-
treated HEK293. Cells expressing the indicated proteins were treated with nocodazole (0.2 mg/mL) and collected at the indicated time points. Cyclin B1
(CCNB1), geminin (GMN), and securin (SEC) amounts were detected. B, mitotic index, determined using anti-phosphoSer10 antibodies and ﬂow
cytometric analysis, of control mock-transfected HEK293 cells and of HEK293 cells transiently expressing the indicated proteins. C and D, hPF,
infected with LND13IDN or with the empty vector (LXIDN), were nocodazole-treated 48 hours after infection for the indicated times (C) or starved
by serum deprivation, released, and analyzed at the indicated time points (D). Cyclin B1 (CCNB1) and securin (SEC) expression was analyzed
by immunoblotting during mitotic block (C) or mitotic entry (D), respectively. Anti-b-actin, loading control.
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nocodazole, HEK293 cells exogenously expressing NUP98 or
NUP98 oncoproteins in did not show any detectable changes in
their mitotic indexes, nor variations in the levels of key cell-
cycle proteins (Supplementary Fig. S3B and S3C), indicating
that NUP98 oncogene expression per se does not cause an
earlier or delayed entry in mitosis.
We then wanted to analyze the effect of NUP98 oncopro-
tein expression on securin accumulation during the cell
cycle in hPFs. NUP98-HOXD13 was exogenously expressed
via retroviral gene delivery (LND13IDN; ref. 36), and cells
were synchronized alternatively by nocodazole treatment or
by serum starvation. Nocodazole-treated NUP98-HOXD13
expressing hPFs (LND13IDN in Fig. 2C) displayed a substan-
tial decrease in securin amounts, starting 16 hours after
nocodazole treatment. No decrease in cyclin B1 amounts
were detected in these same cells (Fig. 2C). hPFs were also
synchronized without resorting to a drug-mediated activa-
tion of the SAC by serum starvation, subsequently released,
and analyzed at different time points for variations of
securin and cyclin B1 amounts. Unlike hPFs transduced
with the control, empty retroviral vector (LXIDN), which
showed normal cyclin B1 and securin accumulation starting
28 hours after release from starvation, hPF cells expressing
NUP98-HOXD13, during the same time frame, displayed
constant, low levels of cyclin B1, and particularly of securin
(Fig. 2D). These results indicate that in hPFs NUP98-
HOXD13 interferes with the control of APC/C activity during
the cell cycle, altogether preventing physiologic securin and
cyclin B1 accumulation. Taken together, our data both in
primary, as well as in immortalized cells, show that the
exogenous expression of NUP98 fusion oncogenes causes an
attenuation of the mitotic spindle checkpoint, revealed by
the aberrant, untimely degradation of securin, pointing to
their possible interference with APC/C function.
NUP98-HOXD13, NUP98-LOC, and NUP98-HHEX
coimmunoprecipitate with both the Cdh1 and the Cdc20
APC/C components
Nup98 was shown to be part, together with its interac-
tion partner Rae1 (37), of the APC/C during mitosis (27); we,
therefore, wanted to verify whether NUP98-HOXD13,
NUP98-LOC, or NUP98-HHEX were capable of physically
interacting with RAE1 and with key components of the
APC/C, thus justifying its deregulation. HEK293 cells ex-
pressing HOXD13, NUP98, NUP98-HOXD13, NUP98-LOC,
or NUP98-HHEX were arrested in mitosis by nocodazole
treatment, and total extracts were prepared for immuno-
precipitation with speciﬁc antibodies against the RAE1,
securin, CDH1, and CDC20 proteins. Control HOXD13, as
anticipated, did not interact with any of the tested APC/C
components (not shown). NUP98 instead was found to
coimmunoprecipitate with the CDH1, but not with the
CDC20 APC/C activators (Fig. 3). Remarkably, NUP98-
HOXD13, NUP98-LOC, and NUP98-HHEX all proved to
efﬁciently coimmunoprecipitate with the RAE1, securin,
CDH1, and CDC20 proteins (Fig. 3). Thus, the tested onco-
proteins are not only still capable of interacting with RAE1
and with the APC/CCdh1, but are in addition aberrantly part
of the APC/CCdc20, providing a possible mechanistic basis
for the observed untimely securin degradation and exit
from mitosis in the presence of an unsatisﬁed SAC.
NUP98-HOXD13, NUP98-LOC, and NUP98-HHEX
interfere with APC/CCdc20 function to induce premature
securin degradation
Wild-type NUP98 has been implicated in the control of
APC/CCdh1 function, and NUP98-controlled APC/CCdh1
claimed to be responsible for securin degradation during
metaphase to anaphase transition (27). As NUP98 fusion
oncoproteins were found to interact with both APC/CCdh1
and APC/CCdc20, we wanted to verify whether the untimely
securin degradation was imputable to misregulation of
APC/CCdh1, APC/CCdc20, or both. To this end, we used
speciﬁc siRNAs to knockdown Cdh1 or Cdc20 in HEK293
cells (Supplementary Fig. S4A). Treatment of control or
NUP98 oncoprotein–expressing HEK293 cells with siRNAs
did not have a detectable effect on the cell cycle in the
presence or absence of nocodazole (Supplementary Fig.
S4B). To assess the effect of NUP98 oncoproteins on APC/C
activity, we used a cell-free system that recapitulates mitotic
checkpoint events (31). Extracts prepared from nocodazole-
arrested HEK293 cells, exogenously expressing NUP98,
NUP98-HOXD13, NUP98-LOC, or NUP98-HHEX, were
allowed to be relieved from mitotic block via incubation at
30!C (31). Although degradation of securin was detectable
only after 90 minutes in extracts from cells expressing
NUP98, or in control untransfected cells (Fig. 4A), in extracts
from HEK293 cells expressing NUP98-HOXD13, NUP98-LOC,
or NUP98-HHEX securin degradation started already after
30 to 60 minutes (Fig. 4A), conﬁrming also in this experi-
mental setting the earlier aberrant degradation of securin
caused by NUP98 fusion oncoproteins. Knocking down of
Cdh1 (Fig. 4D), or the use of a control siRNA (Fig. 4B),
had no effect on NUP98 oncoprotein-induced premature
securin degradation, conversely, knocking down of Cdc20
Figure 3. NUP98-HOXD13, NUP98-LOC, and NUP98-HHEX interact with
RAE1 and associate with APC/C components during mitosis. HEK293
were transfected with expression constructs for NUP98, NUP98-
HOXD13, NUP98-LOC, NUP98-HHEX (ND13, NLOC, and NHHEX), or
HOXD13 (D13). Mitotic extracts were obtained from nocodazole-treated
cells for 16 hours. Samples were subjected to immunoprecipitation
(IP) with the indicated antibodies. Anti-IgG was used as a negative
control. Immunoprecipitated proteins were revealed by immunoblot
analysis with an anti-NUP98 antibody.
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completely abolished it, even at 120 minutes after mitotic
block relieve (Fig. 4C). These results were also conﬁrmed
analyzing securin degradation, after Cdh1 or Cdc20 siRNA-
mediated knockdown, in intact HEK293 cells (Supplemen-
tary Fig. S5).
Our results indicate that, despite the physical interaction
by NUP98 oncoproteins with both APC/CCdh1 and APC/CCdc20,
the induced untimely degradation of securin can be ascribed
uniquely to an aberrant interference with the activity of
APC/CCdc20.
The C-terminal portion of NUP98 contains a functional
PEST sequence
In an attempt to identify possible regulatory domains
within the missing C-terminal region of NUP98 that would
account for the different functional properties of NUP98
oncoproteins, we analyzed the NUP98 protein sequence
in silico searching for novel putative functional motifs.
Using the epestﬁnd application of the EMBOSS package
(38), we identiﬁed a conserved, putative PEST destruc-
tion sequence, localized between amino acids 599 and
616 of the NUP98 protein (Fig. 5A). We thus generated a
deletion mutant of NUP98 lacking this region
(NUP98DP; Fig. 5B), and tested its stability within HEK293
cells in comparison with that of wild-type NUP98 and
of NUP98 fusions. HEK293 cells expressing NUP98-
HOXD13, NUP98-LOC, NUP98-HHEX, NUP98, or HOXD13
were treated with cycloheximmide to block protein syn-
thesis, and the amounts of the expressed proteins were
monitored at different time points by immunoblotting
Figure 4. NUP98-HOXD13, NUP98-
LOC, and NUP98-HHEX interfere
with APC/CCdc20 function.
Immunoblots showing cyclin B1
(CCNB1) and securin (SEC)
degradation after mitotic
checkpoint release. Extracts
prepared from nocodazole-
arrested HEK293 cells expressing
the indicated proteins (left) were
used in a cell-free system
recapitulating mitotic progression.
Mitotic extracts were incubated at
30!C with an ATP-regenerating
system, which rescues checkpoint
activation. Samples were collected
at the indicated times after
incubation. Loading control, anti-
b-actin. A, control and transfected
cells not treated with siRNAs. B,
knockdown experiments using a
control scrambled siRNA in
NUP98, NUP98 oncogene
expressing, or control mock-
transfected HEK293 as indicated.
C, knockdown of CDC20 using a
siRNA in control, NUP98, or NUP98
oncogene expressing HEK293. D,
knockdown of CDH1 using a siRNA
in control, NUP98, or NUP98
oncogene expressing HEK293.
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(not shown). Both wild-type NUP98 and HOXD13 showed
an half-life of approximately 7.5 hours (Fig. 5C), whereas
NUP98-HOXD13, NUP98-HOXD13IQN, NUP98-LOC, NUP98-
HHEX, and the NUP98DP mutant, displayed half-lives
of approximately 29.5, 27.5, >32.0, >32.0, and 31.5 hours,
respectively, indicating that both in the NUP98DP mutant
as well as in the NUP98 fusions the lack of the identiﬁed
PEST sequence causes a considerable increase in the half-
lives of these proteins.
A NUP98 PEST sequence deletion mutant interacts
aberrantly with the APC/CCdc20 and causes premature
securin degradation and chromosome missegregation
As a deletion of the PEST sequence within NUP98
(NUP98DP) was sufﬁcient to mimic the protein half-life of
NUP98 oncoproteins, we next veriﬁed whether the NUP98DP
mutant would recapitulate other aberrant functional proper-
ties of NUP98 oncoproteins. We thus tested whether the
NUP98DP mutant would induce premature securin degrada-
tion and cause chromosome missegregation in HEK293
cells. Twenty-four hours after transfection with the expression
construct for the NUP98DP mutant, cells were nocodazole
arrested and harvested at different time points. Immunoblot
analysis of total cell extracts showed a signiﬁcant decrease
in securin amounts starting 24 hours after nocodazole treat-
ment in cells expressing NUP98DP (Fig. 6A). In parallel,
we veriﬁed whether NUP98DP expression would result in
variations in chromosome numbers and in an increase of
abnormal mitoses. Metaphase spreads of HEK293 cells were
prepared after 48 hours from transfection. Cells expressing
NUP98DP showed substantially increased percentages of
aneuploid ﬁgures and abnormal mitoses, 71% and 34%, re-
spectively (Fig. 6B). We then veriﬁed whether NUP98DP
would aberrantly interact with APC/C components. HEK293
cells expressingNUP98DPwere nocodazole arrested inmitosis,
and total extracts were prepared for immunoprecipitation
with speciﬁc antibodies against the RAE1, securin, CDH1,
and CDC20 proteins. NUP98DP efﬁciently coimmunoprecipi-
tated with RAE1, securin, CDH1, and in addition, similarly
to NUP98 oncoproteins, with CDC20 (Fig. 6C). These results
show that a deletion of the conserved PEST sequence within
NUP98 not only causes a lengthening of the NUP98 half-life
but also seems to be sufﬁcient to recapitulate at least the
aberrant functions of NUP98 oncoproteins concerning SAC
perturbation.
NUP98 oncoproteins or NUP98DP expression reduce
the amount of BubR1 bound to APC/CCdc20
Given the presence of a shared structural motif between
NUP98 and the APC/CCdc20 regulator BubR1 (both display
a functional GLEBS domain; ref. 28), we next wanted to
verify whether the aberrant association of NUP98 oncopro-
teins and NUP98DP with APC/CCdc20 would result in the
premature displacement of BubR1, thus justifying untimely
activation of APC/CCdc20 and mitotic slippage. Using the
cell-free system recapitulating mitotic checkpoint events
described above (31), we analyzed by immunoprecipitation
at different time points extracts from nocodazole-arrested
HEK293 cells, exogenously expressing NUP98, NUP98-
HOXD13, NUP98-LOC, NUP98-HHEX, or NUP98DP, allowed
to be relieved from the block by incubation. At the onset
of incubation (time 0), immunoprecipitation using anti-
CDC20 antibodies followed by immunoblotting using
anti-NUP98 antibodies (Fig. 6D, left), conﬁrmed the physical
interaction of NUP98 oncoproteins and of NUP98DP,
but not of exogenous NUP98 protein (NUP98), with APC/
CCdc20. The amount of BubR1 bound to the APC/CCdc20 at
incubation time 0, as revealed by immunoblotting using
Figure 5. NUP98 contains a functional PEST sequence. A, interspecies
comparison of the NUP98 C-terminal region spanning aa 588 to aa
628. Alignments were performed using the MultAlign tool (46). The
PEST sequence, identiﬁed using the epestﬁnd application
(EMBOSS package), is underlined. B, NUP98 and its mutant
derivatives. GLFG repeats and GLEBS domain are shown as black
and dark gray boxes, respectively. A light gray box represents the
PEST sequence located between aa 599 and aa 616 (NUP98DP), the
NUP98DPEST PEST sequence deletion mutant. C, HEK293 were
transfected with 2 mg of expression plasmid for the indicated
proteins and treated with 100 mg/mL cycloheximmide (CHX)
48 hours after transfection. Cells were harvested at the indicated time
points to prepare total extracts. The amounts of expressed
proteins were analyzed by immunoblotting. Protein levels were
determined by scanning densitometry and normalized against
expression levels of b-actin, as a loading control. The protein decay
at each time point is represented in the graph as percentage of the
protein amount at time zero (100%).
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anti-BubR1 antibodies (Fig. 6D, right), was found to be
consistently lower in extracts from cells expressing NUP98
oncoproteins or NUP98DP with respect to cells expressing
NUP98 (Fig. 6D, bottom). After 60 minutes of incubation,
whereas only a moderate decrease in NUP98 oncoprotein
and NUP98DP binding to APC/CCdc20 was observed (Fig. 6D,
left), BubR1 showed a signiﬁcant reduction of the amount
associated with APC/CCdc20 in all samples (Fig. 6D, bottom),
in correlation with the onset of full APC/CCdc20 activation
and substantial securin degradation at this time point
(cf. Fig. 4A). These results suggest that the association of
NUP98 oncoproteins or NUP98DP with APC/CCdc20 inter-
feres at least partly with the binding of BubR1, thus likely
causing an attenuation of the inhibitory action of BubR1
on APC/CCdc20, and consequently slippage from the unsat-
isﬁed SAC.
Figure 6. NUP98DP interferes with
APC/C function. NUP98
oncoproteins and NUP98DP
displace BubR1 from APC/C. A,
immunoblot analysis showing the
levels of APC/C substrates during
nocodazole treatment in HEK293.
Cells expressing NUP98DP were
treated with nocodazole (0.2
mg/mL), and collected at the
indicated time points. CyclinB1
(CCNB1), geminin (GMN), and
securin (SEC) amounts were
detected. B, mitotic spindle
alterations and aneuploidies
observed in HEK293 expressing
NUP98DP. Of note, 300 mitotic
ﬁgures and mitotic spreads were
analyzed. SD of three independent
experiments is shown. C, HEK293
transfected with expression
constructs for the indicated
proteins. Mitotic extracts were
obtained after 16 hours
nocodazole treatment. Samples
were immunoprecipitated with the
indicated antibodies. An anti-IgG
antibody was used as a negative
control. Immunoprecipitated
proteins were revealed by
immunoblotting with anti-NUP98.
D, top, extracts prepared from
nocodazole-arrested HEK293
expressing the indicated proteins
were used in a cell-free system that
recapitulates mitotic progression
(see legend to Fig. 4). Samples
were collected at the indicated
times after incubation and
subjected to immunoprecipitation
(IP) with anti-CDC20.
Immunoprecipitated proteins were
revealed by immunoblotting with
anti-NUP98 or anti-BubR1.
Bottom, densitometric quantitation
of four independent
immunoprecipitation experiments.
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Discussion
NUP98 is one of the most recurrent partner genes in
chromosomal translocations involved in AML (1, 2). NUP98
fusion partners often include a variety of transcription
factors, mostly represented by their DBDs. Thus, the major-
ity of the current models, proposed to explain the leukemo-
genic action of NUP98 fusion oncoproteins, are centered on
transcriptional misregulation (5). NUP98 fusions, however,
also involve proteins not, or not directly implicated with
transcriptional control, yet they all cause related hemato-
logic malignancies (reviewed in refs. 1, 5). This leaves the
possibility open for additional oncogenic mechanisms,
based on a functional domain(s) shared by most, if not
all, NUP98 fusions. The NUP98 portion, encompassing
the N-terminal half of the protein, and containing both a
GLEBS domain and FG/GLFG repeats, represents a good
candidate for such a functional domain, as it is present in
essentially all NUP98 fusion oncoproteins (1). The capability
of NUP98 to interact via its GLEBS domain with RAE1 and
with the APC/C, and its proposed role in the control of
chromosome segregation during early mitosis (27), pro-
vided an indication as to a possible shared mechanism
through which NUP98 oncoproteins interfere with normal
cell division. Indeed, several NUP98 fusions, including
NUP98HOXA9, NUP98PMX1, and NUP98HOXD13, have
been reported to be associated to kinetochores during
mitosis, and to display a localization pattern similar to that
of APC/C components (39, 40).
Here, we show that three different NUP98 fusion oncopro-
teins, two containing DBDs of known homeodomain transcrip-
tion factors, and one containing a polypeptide of unknown
function, likely unrelated to transcriptional regulation, if
exogenously expressed, substantially perturb chromosome
segregation, causing spindle defects and aneuploidy both
in primary, as well as in immortalized cells. These results
point to a possible interference with APC/C-controlled chro-
mosome separation. We indeed found in cells exogenously
expressing NUP98 fusions, premature exit from mitosis in the
presence of an unsatisﬁed SAC and aberrant securin degra-
dation. In accordance, we found that in hPF, in the absence
of drug-mediated SAC activation, NUP98 oncoprotein expres-
sion prevents normal securin accumulation during cell-cycle
progression.
SAC attenuation and the consequent chromosome mis-
segregation caused by NUP98 oncoproteins rest on their
anomalous interaction with APC/CCdc20. The structural
basis for this aberrant interaction is unclear and will require
further investigation. Intriguingly though, we show that the
deletion of a PEST sequence (41), which we identiﬁed within
the C-terminal portion of the NUP98 protein that is deleted
in all known NUP98 fusion oncoproteins (1), not only has an
effect on the overall stability of NUP98, but causes the
resulting mutant protein (NUP98DP) to acquire at least
some of the aberrant functions of NUP98 oncoproteins, as
NUP98DP aberrantly interacts with APC/CCdc20, interferes
with SAC function, and causes chromosome missegregation.
Deletion of the NUP98 C-terminal portion that includes the
PEST sequence, resulting from the formation of NUP98
oncoproteins, or internal deletion of the PEST sequence,
as in NUP98DP, both lead to an anomalous physical inter-
action with APC/CCdc20, suggesting that the NUP98 N-ter-
minal portion undergoes similar structural alterations in
both conditions. PEST sequences, especially conditional
ones, are held to have an inﬂuence on the local or overall
structure of the proteins possessing them (41). It is thus
tempting to speculate that removal of the PEST sequence
triggers conformational changes within the NUP98 N-termi-
nal portion such as to alter the selectivity of its physical
interactions.
As to the means of aberrant APC/CCdc20 activation, our
results showing a sensible reduction of the BubR1 APC/C
regulator upon NUP98 oncoprotein and NUP98DP expression
point to a mechanism based on direct competition for APC/
CCdc20 binding. Direct competition that could rest on the
structural similarity between the NUP98 N-terminal portion
and BubR1, as both share a functional GLEBS domain (28).
Further work, though, will be required to clarify the detailed
mechanism of BubR1 displacement via NUP98 oncoprotein
binding to APC/CCdc20.
An additional aberrant functional property of the tested
NUP98 fusion oncoproteins revealed to be their substan-
tially increased intracellular stability. Both the increased
intracellular stability and the anomalous interaction of
NUP98 fusion oncoproteins with the APC/CCdc20 represent
dominant functions with respect to wild-type NUP98,
which could combine to account for the dominant onco-
genic action of NUP98 fusions in hematologic malignan-
cies (1, 2, 5).
Whole chromosome instability and the ensuing aneu-
ploidy have been since long held to promote tumorigenesis,
even if their exact role in malignant transformation has
remained elusive (reviewed in ref. 18). Mutant mice models
representing gene defects that cause chromosome instabil-
ity have been shown to be prone to tumorigenesis, indi-
cating that aneuploidy indeed predisposes to oncogenic
transformation (18). Aneuploidy is only rarely observed in
clinical samples from leukemia patients carrying NUP98
fusion oncoproteins. We believe that the dramatically
aneuploid patterns, observed after 48 hours of NUP98
fusion oncoprotein expression, represent an initial effect
of NUP98 fusions within cells. This initial genomic insta-
bility is most likely subsequently overcome by surviving
cells via yet to be deﬁned compensatory mechanisms,
which would allow cells to continue proliferating despite
the interference of NUP98 fusions with APC/C function.
This notion is indeed sustained by our analysis on single-
cell clones stably expressing NUP98-HOXD13, which shows
that viable, NUP98HOXD13-expressing clones, displaying
varying degrees of aneuploidy, or no obvious chromosomal
alterations, can be readily obtained. Chromosome instabil-
ity and aneuploidy promoted by NUP98 oncoproteins could
therefore increase susceptibility to tumor formation, for
instance, by impairing cellular tumor suppressing func-
tions, thus promoting the occurrence of additional muta-
tions (see e.g. refs. 42, 43), such as those reported by
Taketani and colleagues (44), and/or by cooperating with
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additional mechanisms implemented by the individual
NUP98 translocation partner proteins. Accordingly, the
capability of NUP98 oncoproteins to interfere with the SAC
is not necessarily to be considered mutually exclusive with
other possible, transcriptional or nontranscriptional, onco-
genic mechanisms, deployed by the large variety of NUP98
fusions (1). In fact, the oncogenic potential of NUP98
oncoproteins is likely to rest on more than one, coexisting
parallel mechanisms (reviewed in refs. 1, 2, 5). It is, how-
ever, conceivable that a particular NUP98 fusion may
display the prevalence of a partner-speciﬁc, for example,
transcriptionally based, mechanism, as seems to be the case
for the NUP98-HOXA9 fusion (45).
In conclusion, our results showing the involvement of
NUP98 fusion oncoproteins in APC/CCdc20 misregulation
point to a novel mechanism of action shared potentially
by all NUP98 fusions, which could act in combination with
transcriptional misregulation. Moreover, it could account
for the ever-increasing number of NUP98 oncogenic fusions
that cause related hematologic malignancies while involv-
ing partner proteins with diverse biochemical functions.
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